Clinical Trials
8 trialsNCT02858310 2026-03-09
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT01693783 2022-11-08
Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01030562 2018-10-29
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
National Institute of Allergy and Infectious Diseases (NIAID)
Completed
NCT01086709 2018-04-05
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
National Institutes of Health Clinical Center (CC)
Completed
NCT01585428 2018-03-07
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00303823 2015-05-05
Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Phase 2 Completed
NCT00977392 2013-08-07
Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening
National Cancer Institute (NCI)
Completed
NCT00054041 2013-01-24
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Phase 2 Completed